Stockreport

VNRX: Two (2) licensing agreements signed during September, specifically for Nu.Q NETs research related to APS in humans with Werfen S.A. and for Nu.Q Discover services with Hologic Diagen...

VolitionRX Limited  (VNRX) 
NASDAQ:AMEX Investor Relations: ir.volitionrx.com
PDF VolitionRx's (NYSE:VNRX) announcements of two significant licensing agreements in September 2025 represent the materialization of a key priority that was described duri [Read more]